Covid Newscast

The Next-Generation Of Scientific Exploration And Research

Skip to content
  • Categories
    • Discovery
    • Clinical
    • Clinical Trials
    • Long Covid
    • Vaccines
    • Computing
    • Pandemic
    • Antibodies
  • Analytics
  • Resources
  • About Ingentium

Antibodies

Evidence related to Antibody research

  • Literature

  • Media

  • News

  • Antibodies Literature

    Dimerization as a key feature of autoreactive IgA antibody responses.

    December 1, 2025
    Publication date: Nov 28, 2025 The presence of immunoglobulin A (IgA) autoantibodies has been described ...
  • Antibodies Literature

    Longitudinal Study of IgG Antibody Levels Over 4.5 Years Until the Fifth Booster mRNA Vaccination and Breakthrough Infection: A Case Report.

    November 30, 2025
    Publication date: Oct 01, 2025 The differential antibody responses and persistence of immunity following booster ...
  • Antibodies Literature

    Neutralizing antibody responses to the primary series of a COVID-19 mRNA vaccine in the cancer cohort under active treatment.

    November 30, 2025
    Publication date: Dec 01, 2025 Individuals with cancer are at increased risk of severe COVID-19 ...
  • Antibodies Literature

    Longitudinal proteomic and autoantibody signatures after mRNA vaccination in healthy individuals.

    November 30, 2025
    Publication date: Nov 27, 2025 Longitudinal analysis of the circulating proteome after SARS-CoV-2 mRNA vaccination ...
  • Antibodies Literature

    Cytokine and Antibody Isotype Responses in Vaccinated Healthcare Workers with SARS-CoV-2 Breakthrough Infections.

    November 30, 2025
    Publication date: Nov 19, 2025 Healthcare workers (HCWs) are at high risk of breakthrough SARS-CoV-2 ...
  • Antibodies Literature

    Three Years After COVID-19 Vaccination, Anti-Spike SARS-CoV-2 Antibody Concentration Decreases and Is Accompanied by Increasing Anti-Nucleocapsid Seropositivity.

    November 30, 2025
    Publication date: Oct 29, 2025 The anti-spike (S) SARS-CoV-2 antibodies confer neutralizing properties and their ...
  • Antibodies Literature

    Structural Insights into the SARS-CoV-2 Spike Protein and Its Implications for Antibody Resistance.

    November 30, 2025November 30, 2025
    Publication date: Oct 22, 2025 The COVID-19 pandemic, caused by SARS-CoV-2, has profoundly affected global ...
  • Antibodies Literature

    Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolution.

    November 28, 2025
    Publication date: Nov 26, 2025 The receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein ...
  • Antibodies Literature

    Clinical Pharmacology Approaches to Predict Efficacy of Monoclonal Antibodies Against Emerging SARS-CoV-2 Variants.

    November 28, 2025November 28, 2025
    Publication date: Dec 01, 2025 The onset of the global COVID-19 pandemic created an urgent ...
  • Antibodies Literature

    Sero-surveillance of SARS-CoV-2 specific antibody (IgG) among garment workers in Bangladesh.

    November 27, 2025
    Publication date: Nov 25, 2025 Since the first detected COVID-19 case in Bangladesh on March ...
  • Antibodies Literature

    Anti-SARS-CoV-2 antibodies from severe COVID-19 individuals or S2 immunizations do not worsen disease in hamsters.

    November 26, 2025
    Publication date: Nov 24, 2025 Severe COVID-19 associates with humoral immune response dysregulation. While antibodies ...
  • Antibodies Literature

    Rapid decline of SARS-CoV-2-specific salivary IgA antibody levels in people with hybrid immunity-data from the STOPCoV study.

    November 26, 2025
    Publication date: Nov 24, 2025 Hybrid immune individuals who experience an infection after a severe ...
  • Antibodies Literature

    Validation of at-home blood sampling for large scale, cost effective serological analysis for anti-viral antibody responses.

    November 24, 2025
    Publication date: Nov 20, 2025 During the COVID-19 Pandemic in 2020, the need for highly-specific, ...
  • Antibodies Literature

    One thousand SARS-CoV-2 antibody structures reveal convergent binding and near-universal immune escape.

    November 24, 2025
    Publication date: Nov 21, 2025 Understanding antibody recognition and adaptation to viral evolution is central ...
  • Antibodies Literature

    Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic and overall infections.

    November 23, 2025
    Publication date: Nov 21, 2025 Vaccination and prior infection elicit neutralizing antibodies targeting SARS-CoV-2, yet ...
  • Antibodies Literature

    Interferon-mediated NK cell activation increases cytolytic activity against T follicular helper cells and limits antibody response to SARS-CoV-2.

    November 23, 2025
    Publication date: Nov 21, 2025 Natural killer (NK) cells are innate lymphocytes known for their ...
  • Antibodies Literature

    Age-specific antibody profiles of respiratory syncytial virus after COVID-19 pandemic: a sero-epidemiological survey in Taizhou City, Eastern China.

    November 23, 2025
    Publication date: Nov 20, 2025 The generalizability of the current quantitative assessments of age-specific RSV ...
  • Antibodies Literature

    Assessment of SARS-CoV-2 neutralizing antibody persistence using LFIC: a prevalence study after booster doses.

    November 22, 2025
    Publication date: Nov 19, 2025 The primary immunization against SARS-CoV-2 has yielded protection rates of ...
  • Antibodies Literature

    The impact of Omicron infection on antibody response and attenuation: a six-month follow-up study.

    November 21, 2025
    Publication date: Nov 17, 2025 Antibody patterns to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...
  • Antibodies Literature

    COVID-19 antibody testing study: a nested substudy within Alberta’s Tomorrow Project (ATP) in Alberta, Canada.

    November 21, 2025
    Publication date: Nov 13, 2025 The Alberta’s Tomorrow Project (ATP) prospective cohort study was established ...
  • Antibodies Literature

    SARS-CoV-2 Infection Versus Vaccination During Pregnancy: Implications for Placental Antibody Transfer.

    November 20, 2025
    Publication date: Nov 17, 2025 Maternal antibodies are critical for infant protection. We analyzed the ...

Posts navigation

Older posts
ingentium

Ingentium Inc.
Email: support@ingentium.com
© 2016-2025 Ingentium, Inc.

Additional

  • Analytics
  • Contact Us
  • Terms of Service Agreement

Archives

  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}